Role of the Beta1-integrin Subunit in the Adhesion, Extravasation and Migration of T24 Human Bladder Carcinoma Cells
Overview
Authors
Affiliations
The abilities of tumor cells to extravasate from the blood vessel system and to migrate through the connective tissue are prerequisites in metastasis formation. Both processes are chiefly mediated by integrins, which mediate both cell-cell and cell-matrix interactions. We investigated the role of integrin subunits in the adhesion, extravasation and migration of the highly invasive human bladder carcinoma cell line T24. Here we show that inhibition of the beta(1)-integrin subunit using the specific beta(1)-integrin blocking antibody 4B4 significantly reduces the adhesion to HUVEC and transmigratory activity of T24 cells. The blockade of the beta(1)-integrin subunit also resulted in a significantly reduced locomotory activity of T24 cells. A detailed cell migration analysis on a single cell level revealed that blockade of the beta(1)-integrin subunit leads to an altered migration pattern of single cells but does not influence migration per se. Migration parameters such as time active, velocity and distance migrated were significantly reduced as compared to untreated control cells. Our observations strongly suggest a central role for the beta(1)-integrin subunit in forming the cell-cell and cell-matrix bonds necessary for adhesion, extravasation and migration.
Dey D, Hasan M, Biswas P, Papadakos S, Rayan R, Tasnim S Front Oncol. 2022; 12:899009.
PMID: 35719997 PMC: 9198638. DOI: 10.3389/fonc.2022.899009.
Antimetastatic Potential of Rhodomyrtone on Human Chondrosarcoma SW1353 Cells.
Tayeh M, Watanapokasin R Evid Based Complement Alternat Med. 2020; 2020:8180261.
PMID: 32802134 PMC: 7403900. DOI: 10.1155/2020/8180261.
Luong B, Schwenk R, Brautigam J, Muller R, Menche D, Bischoff I PLoS One. 2018; 13(9):e0203053.
PMID: 30204757 PMC: 6133348. DOI: 10.1371/journal.pone.0203053.
Luo J, Yao J, Deng X, Zheng X, Jia M, Wang Y J Exp Clin Cancer Res. 2018; 37(1):23.
PMID: 29426357 PMC: 5807756. DOI: 10.1186/s13046-018-0694-6.
Over forty years of bladder cancer glycobiology: Where do glycans stand facing precision oncology?.
Azevedo R, Peixoto A, Gaiteiro C, Fernandes E, Neves M, Lima L Oncotarget. 2017; 8(53):91734-91764.
PMID: 29207682 PMC: 5710962. DOI: 10.18632/oncotarget.19433.